TRIMEDX Vice President of Product and Portfolio Management TJ Kubricky was featured in a TechNation article about the latest expansion of TRIMEDX-AIQ. TJ explained how the enhanced supply chain capabilities will improve clinical engineering workflows and give teams access to more in-depth insights for operational & capital planning.
TRIMEDX today announced expanded clinical supply chain capabilities with TRIMEDX-AIQ, its AI-native clinical asset intelligence platform. The enhancements integrate automated parts ordering, purchase order automation, and predictive failure forecasting to proactively orchestrate procurement, anticipate equipment failures before disruption occurs, and minimize unplanned downtime.
TRIMEDX Vice President of Product & Portfolio Management TJ Kubricky explained that this update does not replace in-house departments but supports the team members in their decision making.
“These capabilities enhance existing clinical engineering workflows and TRIMEDX-AIQ analytics. They do not replace informatics tools, existing service protocols or client-facing platforms – instead, they make them more proactive and efficient,” he said. “Teams will have access to richer, earlier insights that reduce the time spent performing manual data analysis or reacting to unplanned events. This allows TRIMEDX HTM teams to prioritize higher-value client conversations, proactively prepare clients for upcoming maintenance needs, and support capital and operational planning with greater accuracy. In addition, TRIMEDX leverages multivendor sourcing relationships – including OEMs and third-party suppliers – to expand sourcing options, not remove choice or impose exclusivity.”
“TRIMEDX-AIQ is designed as an enhancement to existing clinical engineering workflows, embedding predictive maintenance and automated supply intelligence into familiar day-to-day operations rather than introducing a new service model,” Kubricky added. “To support adoption, TRIMEDX is ensuring associates have access to AI-related training and enablement, backed by a record $10.8 million investment in technical training in 2025. The company will continue to prioritize training to make sure associates build the skills needed to operate in an increasingly AI-driven environment.”
TRIMEDX-AIQ is powered by one of the healthcare technology management (HTM) industry’s most comprehensive clinical asset datasets, with more than 6.1 million device records, 25+ years of longitudinal insight, and visibility into 90-95% of all active U.S. medical equipment. TRIMEDX’s patent-pending Predictive Work System (PWS) leverages this historical device performance data to identify degradation patterns earlier than ever, providing clinical engineering teams with the ability to prevent or prepare for downtime. Early alerts allow technicians to schedule proactive service windows, reduce clinical workflow disruption, and maintain patient access with the focus on minimizing unplanned downtime.
This expansion goes further by directly linking predictive failures, preventative maintenance forecasting, and routine repairs to automated supply chain workflows. TRIMEDX-AIQ™ identifies and forecasts the right part, at the right time, from the right vendor. This visibility enables operational and finance leaders to plan, and to determine when equipment replacement is most economical.
“Our upgraded, multivendor supply chain capabilities use advanced AI to identify the exact component needed for a predicted failure, select the right supplier, and secure the fastest procurement path—often before a device ever goes offline,” says TRIMEDX CEO Neil de Crescenzo. “By leveraging our long-standing relationships with leading OEMs and third-party suppliers, we’re able to deliver accelerated access to parts, and expanded sourcing options that many organizations simply can’t achieve on their own.”
This proactive model results in significantly shorter turnaround time, fewer secondary failures, and far less disruption to patient schedules and throughput. Unplanned downtime can cost hospitals thousands of dollars in lost patient revenue and create weeks-long patient scheduling delays. These operational improvements quickly scale into a major financial impact.
With these enhanced supply chain capabilities and PWS developments, TRIMEDX-AIQ™ is advancing the next chapter of AI-native clinical asset intelligence. By combining earlier failure detection, proactive sourcing, and system-level forecasting through TRIMEDX-AIQ ™, it gives health systems a more reliable path to maximize availability, minimize disruption, and protect the revenue & patient access that depend on consistent uptime.